Healthy Skepticism Library
Items published in 2005
There are 1256 items in the Healthy Skepticism Library that were published in 2005.
Page 11 of 13 pages ‹ First < 9 10 11 12 13 >
HSL1815
Rentmeester CA.
Pharma PR or medical education?
Hastings Cent Rep 2005 Mar-Apr; 35:(2):6
HSL1816
Roselin JM.
Pharma PR or medical education?
Hastings Cent Rep 2005 Mar-Apr; 35:(2):5-6
HSL1817
Sweeney HA.
Pharma PR or medical education?
Hastings Cent Rep 2005 Mar-Apr; 35:(2):4
HSL2283
De Bruin ML, Pettersson M, Meyboom RH, Hoes AW, Leufkens HG.
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.
Eur Heart J 2005 Mar; 26:(6):590-7
http://eurheartj.oxfordjournals.org/cgi/content/full/26/6/590
HSL4599
Torg J.
Vioxx and Merck: a preventable situation?
Orthopedics 2005 Mar; 28:(3):248,
HSL4600
Mather C.
The pipeline and the porcupine: alternate metaphors of the physician-industry relationship.
Soc Sci Med 2005 Mar; 60:(6):1323-34
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4D5JSJJ-2&_coverDate=03%2F01%2F2005&_alid=398122182&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=a3b4c00f922432b53675cfc8e056c2cd
HSL4892
Arellano FM.
The withdrawal of rofecoxib.
Pharmacoepidemiol Drug Saf 2005 Mar; 14:(3):213-7
http://www3.interscience.wiley.com/cgi-bin/abstract/109930237/ABSTRACT?CRETRY=1&SRETRY=0
HSL4897
Shatin D, Gardner JS, Stergachis A, Blough D, Graham D.
Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants.
Pharmacoepidemiol Drug Saf 2005 Mar; 14:(3):149-54
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3058&uid=15386714&db=PubMed&url=http://dx.doi.org/10.1002/pds.961
HSL5352
Nikles CJ, Clavarino AM, Del Mar CB.
Using n-of-1 trials as a clinical tool to improve prescribing.
Br J Gen Pract 2005 Mar; 55:(512):175-80
http://www.ingentaconnect.com/content/rcgp/bjgp/2005/00000055/00000512/art00004?token=005d1ffc0c8db86dc67676568293c62207d673f582f6b6d383a4b3b257b507b425f246a433b316373425cf34c897f
HSL838
Herper M.
Tysabri Is No Vioxx
Forbes.com 2005 Feb 28
HSL7813
Barrett A.
Pfizer's Funk
Business Week 2005 Feb 28
http://www.businessweek.com/magazine/content/05_09/b3922001_mz001.htm?chan=search
HSL837
Tansey B.
Hard sell: How marketing drives the pharmaceutical industry: The side effects of drug promotion: Aggressive ads for painkillers left more patients exposed to risks
The San Francisco Chronicle 2005 Feb 27
HSL833
Frith M.
Dramatic increase in overdoses linked to antidepressants
The Independent 2005 Feb 25
HSL834
Harris G, Berenson A.
10 Voters on Panel Backing Pain Pills Had Industry Ties
THE NEW YORK TIMES 2005 Feb 25
HSL836
Welsh M.
Drug reactions harm, even kill, elderly: Study
The Toronto Star 2005 Feb 25
HSL1115
New CCPA study charges Health Canada with abandoning its duty to protect Canadians' health and safety
Canadian Centre for Policy Alternatives 2005 Feb 25
HSL1608
Mansfield PR.
Beliefs and plans of GP registrars before and after a 90 minute talk about drug promotion
Unpublished 2005 Feb 25;
HSL5151
Tarzwell R.
Reader's response to the webcast video editorial entitled 'the institute for one world health--a not-for-profit pharmaceutical company'.
MedGenMed 2005 Feb 25; 7:(1):34
https://profreg.medscape.com/px/getlogin.do?urlCache=aHR0cDovL3d3dy5tZWRzY2FwZS5jb20vdmlld2FydGljbGUvNDk5Mzk5
HSL832
Picard A.
Drugs aren't commodities to be hustled like cars and cookies
The Boston Globe and Mail 2005 Feb 24
HSL826
Abraham C.
Health Canada too slow to act on drug-safety plan, experts say
Boston Globe and Mail 2005 Feb 23
HSL831
Are GPs in thrall to the drug companies?
The Daily Telegraph 2005 Feb 23
HSL835
Weiss R.
NIH Clears Most Researchers In Conflict-of-Interest Probe
The Washington Post 2005 Feb 23
HSL5327
Dreyfuss BT.
Patents pending
Am Prospect. 2005 Feb 23;
http://www.prospect.org/web/page.ww?section=root&name=ViewWeb&articleId=9237
HSL820
Timmons H, Wright T.
Novartis to Buy Two Makers of Generics
2005 Feb 22
HSL821
Faunce T.
Novartis hits acquisition trail
2005 Feb 22
HSL822
Martinez B.
A Vioxx Comeback Could Tilt Balance in Merck Litigation
THE WALL STREET JOURNAL 2005 Feb 22
HSL823
Winslow R, Won TESORIERO, Wilde MATHEWS.
Where Findings On Painkillers Leave Patients: FDA Panel's Recommendations Could Revive Merck's Vioxx; Balancing the Risks With Relief
THE WALL STREET JOURNAL 2005 Feb 22
HSL824
Abraham .
Weak law blamed in Vioxx case
The Boston Globe and Mail 2005 Feb 22
HSL825
Associated Press.
Another wee problem noted with HRT
Associated Press 2005 Feb 22
HSL827
BBC News.
Rules issued on patient restraint
BBC News 2005 Feb 22
HSL5575
Herxheimer A.
Communicating with Patients about Harms and Risks
PLoS Med 2005 Feb 22; 2:(2):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020042
HSL240
Mansfield PR, Vitry AI, Wright JM.
Withdraw all COX-2-selective drugs.
Med J Aust 2005 Feb 21; 182:(4):197
http://www.mja.com.au/public/issues/182_04_210205/matters_arising_210205_fm-1.html
HSL819
Carvel J.
Lack of information worries NHS patients
The Guardian 2005 Feb 21
HSL829
Canwest NEWS.
Firm to cut off drug supply: Hospitals owe thousands for Fabry drugs
Ottawa Citizen 2005 Feb 21
HSL828
Graham J, James F.
Flaws in Drug Agency Put Consumer at Risk
The Chicago Tribune 2005 Feb 20
HSL812
U.S. committee OKs all 3 arthritis drugs
CBC News 2005 Feb 19
HSL813
Wilde MATHEWS, Hensley S.
Merck May Return Vioxx to Market Move Depends on Whether FDA Panel Decides Risks Exist in Similar Medicines
THE WALL STREET JOURNAL 2005 Feb 18
HSL815
Antidepressants increase risk of suicidal behaviour: study
CBC News 2005 Feb 18
HSL19044
Larson RJ, Woloshin S, Schwartz LM, Welch HG.
Celebrity endorsements of cancer screening.
J Natl Cancer Inst 2005 Feb 18; 97:(9):693-5
http://jnci.oxfordjournals.org/content/97/9/693.long
HSL814
Davis M.
FDA Maverick Whips Merck, Pfizer
TheStreet.com 2005 Feb 17
HSL830
Heavey S, Richwine L.
FDA Scientist Questions Need for COX-2 Drugs
Reuters 2005 Feb 17
HSL810
Harris G.
Drug Industry's Longtime Critic Says 'I Told You So'
The New York Times 2005 Feb 15
HSL7412
Cooper RJ, Schriger DL.
The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.
CMAJ 2005 Feb 15; 172:(4):487-91
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15710940
HSL1128
UCLA study: Nearly a third of drug ads in medical journals contain no references for medical claims
University of California - Los Angeles 2005 Feb 14
HSL1130
Truth in advertising
Canadian Medical Association Journal 2005 Feb 14
HSL818
MacPherson K, Silverman E.
Drug makers now confront unlikely foe in labs: Science discovery of medicines slows despite billions in investments
The New Jersey Star-Ledger 2005 Feb 13
HSL808
Harris G.
Drug Regulators Are Trying to Quash Study, Senator Says
The New York Times 2005 Feb 12
HSL806
Meier B, Saul S.
Marketing of Vioxx: How Merck Played Game of Catch-Up
The New York Times 2005 Feb 11
HSL807
Wilde MATHEWS, Anand G, Davies P.
Why U.S., Canada Differ on Safety Of Attention-Deficit Drug
THE WALL STREET JOURNAL 2005 Feb 11
HSL811
Harris G, Carey B.
Senator charges FDA interceded for drug: Grassley says agency asked Canada not to ban Adderall XR
The New York Times 2005 Feb 11
HSL889
Associated Press.
Film Exposes Pharmaceutical Secrets
Forbes.com 2005 Feb 10
HSL5425
Steinbrook R.
Commercial support and continuing medical education.
N Engl J Med 2005 Feb 10; 352:(6):534-5
http://content.nejm.org/cgi/content/extract/352/6/534
HSL804
Metherell M.
Generic drug price cut limited to one-off
The Sydney Morning Herald 2005 Feb 8
HSL805
Emory Study Reveals the Huge Influence of Direct-to-Consumer Drug Advertisements
HealthOrbit, Inc. - News Details 2005 Feb 8
HSL1606
Wofford JL, Ohl CA.
Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
BMC Med Educ 2005 Feb 8; 5:(1):5
http://www.biomedcentral.com/content/pdf/1472-6920-5-5.pdf
HSL801
Faunce T.
Time to gear up for the generic v brand-name drugs showdown: Officials dealing with the trade deal must not sideline public input
The Sydney Morning 2005 Feb 7
HSL802
Dodson L.
Cabinet to reassess price cut for generic drugs
The Sydney Morning Herald 2005 Feb 7
HSL803
Bouma J, Brandt E.
Money and pills
Trouw (Netherlands) 2005 Feb 5
HSL3707
Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA.
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.
Lancet 2005 Feb 5-11; 365:(9458):475-81
http://linkinghub.elsevier.com/retrieve/pii/S0140673605178647
HSL800
Anti-depressants pregnancy risk
BBC News 2005 Feb 4
HSL816
Reuters .
Antidepressants may harm newborns: Study: Infants face possible side effects of withdrawal
MSNBC.com 2005 Feb 4
HSL1133
Australia - United States Free Trade Agreement (AUSFTA) & the Pharmaceutical Benefits Scheme (PBS) Statement on the Implementation of Australia's AUSFTA Commitments 4th February 2005
2005 Feb 04
http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2005-ta-abb008.htm?OpenDocument&yr=2005&mth=02
HSL798
Rochon-Ford A, Armstrong L.
Cancer war tells only half of story
Toronto Star 2005 Feb 3
HSL788
Hensley S.
Pfizer Disputes New Allegation Of Failure to Publish Test Data
THE WALL STREET JOURNAL 2005 Feb 2
HSL791
Willman D.
NIH Seeks 'Higher Standard':Banning staff deals with drug firms will help set an ethical example, the agency director says.
THE LOS ANGELES TIMES 2005 Feb 2
HSL792
Harris G.
Agency Scientists Divided Over Ethics Ban on Consulting
THE NEW YORK TIMES 2005 Feb 2
HSL793
Vedantam S.
Fewer Kids Prescribed Drugs for Depression Sharp Decrease Seen After Reports of Risks
The Washington Post 2005 Feb 2
HSL797
Ivanhoe NEWSWIRE.
Statin Risks
News 14 Carolina 2005 Feb 2
HSL20080
Kelly S
HCN denies Medical Director breaches advertising code
Medical Observer 2005 Feb 22
HSL789
Willman D.
NIH to Ban Deals With Drug Firms: Federal researchers will no longer be able to accept fees to consult for companies, officials say. The lucrative pacts have sparked ethics probes.
The Los Angeles Times 2005 Feb 1
HSL790
Harris G.
Ban on Federal Scientists' Consulting Nears
THE NEW YORK TIMES 2005 Feb 1
HSL796
Kirkey S.
Children's drugs an 'educated guess'
The Ottawa Citizen 2005 Feb 1
HSL1499
Berenson A, Harris G.
Pfizer Says 1999 Trials Revealed Risks With Celebrex
The New York Times 2005 Feb 1
HSL3798
Neuhaus J.
[Quality requirements for investigational medicinal products. The state authorities' point of view]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005 Feb 01; 48:(2):189-95
http://scienceserver.cilea.it/cgi-bin/sciserv.pl?collection=journals&issn=14369990&volume=48&issue=2&firstpage=189
HSL4956
Krishnan E.
Unregistered trials are unethical.
PLoS Med 2005 Feb 01; 2:(2):e48
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15737003
HSL5298
Stewart M, Marshall JN, Ostbye T, Feightner JW, Brown JB, Harris S, Galajda J.
Effectiveness of case-based on-line learning of evidence-based practice guidelines.
Fam Med 2005 Feb 01; 37:(2):131-8
http://www.stfm.org/fmhub/fm2005/February/Moira131.pdf
HSL6042
Earle L, Kelly L.
Coping strategies, depression, and anxiety among Ontario family medicine residents.
Can Fam Physician 2005 Feb 01; 51:242-3
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16926935
HSL799
Goldstein N.
Important Leadership Lessons from Outer Space Exploration
Inside Influence Report 2005 Feb
HSL13603
Alpert JS.
Doctors and the drug industry: how can we handle potential conflicts of interest?
Am J Med 2005 Feb; 118:(2):99-100
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(04)00751-X
HSL782
Alarm sounded on ads in doctors' software
Australian Financial Review 2005 Jan 30
HSL786
Editorial .
Corporate Welfare Runs Amok
THE NEW YORK TIMES 2005 Jan 30
HSL787
Fulbright L.
Kaiser bans painkiller Bextra
San Francisco Chronicle 2005 Jan 30
HSL783
Shimron Y, Gardner A.
Cream's safety wasn't tested: 'Compound drugs' lightly regulated
The News & Observer Publishing Company 2005 Jan 29
HSL809
Szalavitz M.
Opioids could offer mass market pain relief
New Scientist 2005 Jan 29
HSL780
Griffin K.
Putting a price on human life: As health costs soar, should PharmaCare pay for expensive but unproven drugs for rare diseases?
The Vancouver Sun 2005 Jan 28
HSL784
Associated Press.
Acne Drug Memos Kept Secret Despite Suits
Associated Press 2005 Jan 28
HSL785
Willman D.
NIH Seeks Outside Inquiry of Scientist: Agency ethics officials target an Alzheimer's researcher who accepted more than $500,000 from a drug company and didn't report it.
THE LOS ANGELES TIMES 2005 Jan 28
HSL779
Naik G.
More AIDS Drugs Get to the Poor
THE WALL STREET JOURNAL 2005 Jan 27
HSL817
Reuters .
Lilly Says UK Medical Journal Retracts Prozac Claim
2005 Jan 27
HSL3683
Berndt ER.
To inform or persuade? Direct-to-consumer advertising of prescription drugs.
N Engl J Med 2005 Jan 27; 352:(4):325-8
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=15673797&db=pubmed&url=http://content.nejm.org/cgi/pmidlookup?view=short&pmid=15673797
HSL768
Hallam K, Jensen K.
Pfizer Faces Republican Assault on Drug Import Ban
Bloomberg News 2005 Jan 26
HSL1200
Health and environment advocates cautious about "Campaign to Control Cancer": Funding sources questioned
Women and Health Protection 2005 Jan 26
HSL766
Bull Riding and Cancer Treatment
New York Times 2005 Jan 25
HSL767
Abelson , Pollack A.
Patient Care vs. Corporate Connections
The New York Times 2005 Jan 25
HSL775
Cresswell A.
Drug companies threaten price hikes
The Australian 2005 Jan 25
HSL776
Limprecht E.
Patient data taken without GPs' consent
The Australian Doctor 2005 Jan 25
HSL763
Technology reminds sick to take pills
Business Day 2005 Jan 24
HSL765
Otto , A .
A fatal flaw: Sometimes the drugs designed to help people battling depression do more harm than good
THE NEWS TRIBUNE 2005 Jan 24
HSL794
Barclay L.
More Evidence on Cardiovascular Risks of COX-2 Inhibitors, Other NSAIDs
Medscape Medical News 2005 Jan 24
HSL762
Kolata , G .
Rapid Rise and Fall for Body-Scanning Clinics
The New York Times 2005 Jan 23
Page 11 of 13 pages ‹ First < 9 10 11 12 13 >
